戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ells, but T cell viability was greater under sequential treatment.
2 forkhead box M1, which was not observed with sequential treatment.
3 a: 36 received simultaneous treatment and 62 sequential treatment.
4 moradiotherapy now seems more effective than sequential treatment.
5 hese were not as pronounced as observed with sequential treatment.
6                                        After sequential treatment, 11 (85%) of 13 patients achieved a
7 st visit had better stereopsis outcomes with sequential treatment (5.12 [IQR, 4.00-7.51] log stereops
8                   Ten-day Levofloxacin-based sequential treatment achieved inadequate efficacy rate (
9 including an AI as primary monotherapy or as sequential treatment after 2 to 3 years of tamoxifen yie
10  treatment, either as up-front therapy or as sequential treatment after tamoxifen.
11 atment for controlled patients (arm B), or a sequential treatment alternating gemcitabine and fluorou
12      Depression subjects were drawn from the Sequential Treatment Alternatives to Relieve Depression
13 2 in one (0.8%) of 130 patients who received sequential treatment and four (2.9%) of 137 patients who
14  A combination of novel drugs with ASCT in a sequential treatment approach can attain long-term survi
15              The APPLE trial suggests that a sequential treatment approach is associated with more fr
16  nontoxic end products is attainable using a sequential treatment approach with three mixed anaerobic
17 egrate the novel agents for CLL therapy into sequential treatment approaches in the near future.
18                               Multimodal and sequential treatments are relatively frequent in post-LT
19  high-quality studies with 728 patients in a sequential treatment arm and 682 in a control treatment
20 ury occurred in 2, 7, and 3 early, late, and sequential treatment arm patients, respectively.
21 son-years in the early, late integrated, and sequential treatment arms, respectively.
22                                   Apart from sequential treatment assignment, reduced adherence was a
23 ing selection for greater thermostability by sequential treatment at progressively higher temperature
24 rance of the bacterium can be achieved using sequential treatments at antibiotic dosages so low that
25 tment of HSV-1 virions with pH 5 or multiple sequential treatments at pH 5 followed by neutral pH cau
26 hemical expansion of graphite is achieved by sequential treatment, beginning with the established met
27 lls showed an additive survival effect after sequential treatment, but a toxic effect was observed af
28         We have identified a safe and active sequential treatment combination of azacitidine and lena
29 cells were more effective when combined with sequential treatment compared with monotherapy treatment
30 tigator-initiated, phase 2 study evaluates a sequential treatment consisting of a debulking with two
31 5 years of an aromatase inhibitor alone, and sequential treatment consisting of tamoxifen with cross
32 horts in oncology and other fields requiring sequential treatment decisions.
33                    A screen of 136 96-h-long sequential treatments determined five of these that coul
34  were examined using the following keywords: sequential treatment, drugs and psychotherapy, combined
35 neic hematopoietic cell transplantation in 2 sequential treatment eras, to determine whether those tr
36 d patching therapy at their first visit) or "sequential treatment" (glasses alone at first visit, fol
37 sible to assess IRIS in more patients in the sequential treatment group (n = 74) than in the late int
38 weeks after tuberculosis therapy completion (sequential treatment group).
39 n the early integrated, late integrated, and sequential treatment groups, respectively.
40 n the early integrated, late integrated, and sequential treatment groups, respectively.
41 .5%, 95% CI 47.8-64.9) patients who received sequential treatment had a pathological complete respons
42               Safety was analyzed throughout sequential treatment in all participants who received at
43  resulted in increased survival when used as sequential treatment in both breast cancer and NSCLC.
44  ganciclovir (GCV) was less efficacious than sequential treatment in human DU145 prostate carcinoma c
45                                              Sequential treatments in O(2) and H(2) formed small (app
46  of two synergistic antibiotics to so-called sequential treatments in which the choice of antibiotic
47                                         This sequential treatment induced phosphorylation of p53 at S
48 se of Pseudomonas aeruginosa to experimental sequential treatments involving both heterogenous and ho
49                                              Sequential treatments involving tamoxifen and letrozole
50 (cisPt)) as the main delivery system for the sequential treatment led to the reduction in tumor strom
51                                     RPM as a sequential treatment markedly inhibited mRNA levels codi
52                                              Sequential treatment of 2,3-dichloropropene with magnesi
53 ained in a one-pot process, which involves a sequential treatment of 2,6-dichloropurines with a selec
54                                              Sequential treatment of a conformationally biased allyli
55                           Here, we show that sequential treatment of AML blasts with decitabine follo
56                                  Purpose The Sequential Treatment of CD20-Positive Posttransplant Lym
57                   The method is based on the sequential treatment of cell walls with specific hydroly
58                                              Sequential treatment of decitabine followed by selinexor
59  with PEGylated IFN-alpha, and patients with sequential treatment of Entecavior and PEGylated IFN-alp
60                                Additionally, sequential treatment of H-phosphinothioates by a strong
61                                 Importantly, sequential treatment of HL-60 cells with etoposide, Ara-
62                                 Furthermore, sequential treatment of hPSCs with glycogen synthase kin
63 silencing of this HSC genetic program by the sequential treatment of human cord blood CD34(+) cells w
64  mass spectrometry-based method that employs sequential treatment of intact glycopeptides with enzyme
65                                              Sequential treatment of macrophages with multiple cytoki
66                                          The sequential treatment of nude mice with chemotherapeutic
67 tudied the efficacy of administering a novel sequential treatment of parenteral ACK2, an antibody tha
68 ease, with an impact on the evolution of the sequential treatment of patients with HCC.
69                                 Importantly, sequential treatment of PC-3, DU145, and LNCaP cells wit
70                                          The sequential treatment of peanuts by ultrasonication-tryps
71                                 Furthermore, sequential treatment of PMF CD34(+) cells but not normal
72                                          The sequential treatment of PMF CD34+ cells with the chromat
73 ions, was demonstrated experimentally by the sequential treatment of spirochetes with Fab-CB2 and mon
74 d a study to assess whether or not selective sequential treatment of the more diseased upper lobe seg
75 tion of activity by dithiothreitol following sequential treatment of the V-ATPase with SNG and N-ethy
76 stic reactivation of CDKN2A is observed upon sequential treatment of Tu159 cells with both 5-aza-dC a
77                                          The sequential treatment of ultrasonication followed by acid
78 of the leaderless polypeptide IL-1 beta, but sequential treatment of wild-type, but not P2X(7)R-defic
79                                 Parallel and sequential treatments of ejaculated and capacitated sper
80                                              Sequential treatments of the hair bundles with BAPTA and
81 s were heterogeneous, and no trials compared sequential treatments or different durations of drug hol
82 ger (18.1 versus 10.3 weeks) to respond to a sequential treatment paradigm (adding a selective seroto
83 re critical to understanding the benefits of sequential treatment (parathyroid hormone followed by an
84                 Toxicity management and, for sequential treatments, patient and physician awareness,
85 ed to optimize the drug combinations used in sequential treatment plans-that is, optimized sequences
86 veloping a novel methodology to assess these sequential treatment processes.
87                                          The sequential treatment produced the greatest induction of
88 east cancer and may be feasible as part of a sequential treatment program including anthracyclines.
89                Patients randomly assigned to sequential treatment received fluorouracil 500 mg/m(2),
90                                         This sequential treatment regimen is highly effective as fron
91 pproved antiretroviral agents, the number of sequential treatment regimens that will be effective for
92 ersonal psychotherapy and an 8-week delay in sequential treatment response among women with recurrent
93 orescent protein-alpha-tubulin revealed that sequential treatment resulted in G2 checkpoint abrogatio
94                                            A sequential treatment schedule increases toxicity but may
95      Whole-liver treatment was achieved with sequential treatment sessions in most patients, with sel
96            Sensitivity analyses suggest that sequential treatment strategies optimized 10-year diseas
97                      The authors evaluated a sequential treatment strategy of fluoxetine and relapse-
98                   PFS is promising, and this sequential treatment strategy should be further investig
99                                We explored a sequential treatment strategy to allow safe delivery of
100 llectively, these results show that a novel, sequential treatment strategy with a CDK4/6 inhibitor fo
101 ing the question of whether a combination or sequential treatment strategy with immunotherapy is supe
102  be carefully deployed and not all sublethal sequential treatments succeed.
103 sistance pathways could aid in the design of sequential treatments that can elicit and take advantage
104 heckpoint abrogation and mitotic death after sequential treatment, this was not accompanied by an inc
105                                Comparison of sequential treatments to letrozole monotherapy included
106                                 In contrast, sequential treatment was antagonistic and had a minimal
107 tion rate obtained with Clarithromycin-based sequential treatment was significantly higher than with
108 and HCT8 colorectal carcinoma cells, whereas sequential treatments were additive at best.
109                                              Sequential treatments were associated with higher rates
110                                        These sequential treatments were largely excluded in phase 2 a
111 rs of tamoxifen or letrozole monotherapy, or sequential treatment with 2 years of one of these drugs
112                                        Last, sequential treatment with 5-aza-2'-deoxycytidine followe
113 th a significant delay of tumor growth after sequential treatment with ABT-263.
114 e influenced in response to thapsigargin and sequential treatment with acetylcholine.
115                                 Survivors of sequential treatment with Adriamycin and FUdR (MCF-7 A/F
116 sing single-cell analysis, we found that the sequential treatment with an inhibitor of poly(ADP-ribos
117      Importantly, our data also suggest that sequential treatment with BET and p300 inhibition may pr
118                Furthermore, differential and sequential treatment with blocking antibodies directed a
119 veloped to regenerate articular cartilage by sequential treatment with BMP2 and BMP9 (or GDF2) that p
120                     Twenty patients received sequential treatment with both dasatinib and nilotinib f
121  that this homing defect can be corrected by sequential treatment with chromatin-modifying agents.
122                                              Sequential treatment with cisplatin followed by ABT-263
123                                              Sequential treatment with CMAs, therefore, represents a
124 2V617F(+) HPCs and SRCs can be eliminated by sequential treatment with CMAs.
125 al of 226 patients were randomly assigned to sequential treatment with cytarabine and infusional DNR
126                                              Sequential treatment with decitabine and cytarabine was
127      The 3T3-L1 adipocytes differentiated by sequential treatment with dex and IBMX displayed insulin
128                                              Sequential treatment with Epo B followed by FP induced s
129 s attenuated the lordosis response following sequential treatment with estradiol and progesterone.
130 mic skeletal muscles, which was sustained by sequential treatment with fluvastatin.
131 ferative Disorder (PTLD-1) trial established sequential treatment with four cycles of rituximab follo
132          Laboratory data have suggested that sequential treatment with granulocyte-macrophage/colony-
133 imerized to its trans-fused counterpart 2 on sequential treatment with iodosylbenzene then sodium bor
134 bstantial intraocular bleeding compared with sequential treatment with low-molecular-weight heparin a
135 pathway activity were the best responders to sequential treatment with LSD1 inhibitors then trametini
136 06 samples from 33 patients who had received sequential treatment with multiple TKIs and had experien
137                                 Furthermore, sequential treatment with paclitaxel followed by ET-743
138                  Our study demonstrated that sequential treatment with PARPi and WEE1i spared T cells
139                            It was found that Sequential treatment with Se-NP solution and PAW increas
140  E14 ES cells into mature granule neurons by sequential treatment with secreted factors (WNT1, FGF8,
141                                        Thus, sequential treatment with senolytics might be an additio
142  present in J774A.1 cells, was eliminated by sequential treatment with small hairpin RNA expressing l
143                                              Sequential treatment with SN-38 followed by UCN-01 resul
144 dine (26) with selenium dioxide, followed by sequential treatment with sodium borohydride, methanesul
145                                    Following sequential treatment with sodium butyrate and the carcin
146 CH -respiring bacteria and demonstrates that sequential treatment with specialized anaerobic cultures
147                                  The ordered sequential treatment with SWCNTs and H(2)O(2) or NaOCl r
148 trial confirm that both exemestane alone and sequential treatment with tamoxifen followed by exemesta
149 genotypes in CML patients who relapsed after sequential treatment with the ABL inhibitors imatinib an
150          We have explored the effects of the sequential treatment with the DNA methyltransferase inhi
151                                              Sequential treatment with the F(ab')2 fragment of anti-F
152 ffered external solution was recorded during sequential treatment with the potassium ionophore valino
153                                 In contrast, sequential treatment with these two agents in either ord
154  preliminarily assess the clinical safety of sequential treatment with tirofiban or eptifibatide foll
155                                              Sequential treatment with two different amino acids sepa
156                                              Sequential treatments with antibiotics that target diffe
157        Other samples of MV were subjected to sequential treatments with enzymes, salt solutions, and
158 th TRAIL-sensitive and -resistant cells upon sequential treatments with HDAC inhibitors followed by T
159                                    Thus, the sequential treatments with HDAC inhibitors followed by T
160                                              Sequential treatments with heat and chymotrypsin caused
161  upfront treatments, their cardiotoxicity as sequential treatments with tamoxifen remains unknown.

 
Page Top